Skip to content

Examining the effect of combined therapy in reducing obsessions in adolescents

Comparison of the Effectiveness of Transdiagnostic Unified Protocol with Pharmacotherapy on the Severity of Symptoms and Emotion Regulation in Adolescents with Obsessive-Compulsive Disorder Comorbid with Anxiety Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241004063254N1
Enrollment
48
Registered
2025-03-03
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: obsessive-compulsive disorder. Condition 2: anxiety disorders. Condition 3: anxiety disorders. Obsessive-compulsive disorder Phobic anxiety disorders Other anxiety disorders

Interventions

Intervention 1: Intervention Group: Adolescents aged 12-17 with Obsessive-Compulsive Disorder comorbid with anxiety disorders who will receive transdiagnostic treatment in addition to medication. This
2_ Familiarization with emotions and behaviors (2 or 3 sessions)
3_ Introducing emotion-focused behavioral experiments (1 or 2 sessions)
4_ Awareness of bodily sensations (1 or 2 sessions)
5_ Having flexible thinking (2 or 3 sessions)
6_ Awareness of emotional experiences (1 or 2 sessions)
7_ Facing emotion-provoking situations (2+ sessions)
8_ Reviewing achievements and looking ahead (1 session)
9_ Parenting emotional adolescents (3-1 sessions). The sessions will be 90 minutes in duration, conducted on a weekly basis (one to two sessions per week), over a three-month period. Drug therapy in
it is also worth mentioning that the groups will be matched based on their medication dosage. Intervention 2: Control Group: this group will only receive medication. Drug therapy in the present study
it is also worth mentioning that the groups will be matched based on their medication dosage.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Age range: 12 to 17 years old Presence of obsessive-compulsive disorder (OCD) symptoms comorbid with anxiety disorders Willingness to participate in the research Informed consent Parental consent for adolescent participation in the study

Exclusion criteria

Exclusion criteria: Concurrent participation in other psychotherapy sessions Diagnosis of other psychiatric disorders including Attention Deficit Hyperactivity Disorder (ADHD), intellectual disability, autism spectrum, psychosis, bipolar disorder Presence of medical conditions that may interfere with the research process Substance abuse

Design outcomes

Primary

MeasureTime frame
Emotion regulation score in the Difficulties in Emotion Regulation Scale (DERS). Timepoint: Measuring emotion regulation before the intervention begins (pre-test), one week after the intervention ends (post-test), And a follow-up will be conducted 3 months after the intervention is completed. Method of measurement: Difficulties in Emotion Regulation Scale (DERS).;Obsessive severity score in the Obsessive-Compulsive Questionnaire by Fava and colleagues. Timepoint: Measuring obsessive severity before the intervention begins (pre-test), one week after the intervention ends (post-test), And a follow-up will be conducted 3 months after the intervention is completed. Method of measurement: The Obsessive Compulsive Inventory_ Child Version (OCI-CV), was developed by Foa and colleagues.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoghaye Fallah

Tabriz University of Medical Sciences

roghayefallah32@gmail.com+98 914 745 9344

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026